Literature DB >> 7914668

Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency.

L Ratnakumari1, I A Qureshi, R F Butterworth.   

Abstract

Congenital deficiencies of the urea cycle enzyme ornithine transcarbamylase (OTC) result in chronic hyperammonemia and severe neurological dysfunction including seizures and mental retardation. As part of a series of studies to elucidate the pathophysiologic mechanisms responsible for the CNS consequences of OTC deficiency, concentrations of ammonia-related and neurotransmitter amino acids were measured as their o-phthalaldehyde derivatives using high performance liquid chromatography with fluorescence detection in regions of the brains of sparse-fur (spf) mice, a mutant with an X-linked inherited defect of OTC. Compared to CD-1/Y controls, the brains of spf/Y mutant mice contained significant alterations of several amino acids. A generalized, up to 2-fold, increase of brain glutamine was observed, consistent with the exposure of these brains to increased concentrations of ammonia. Significant increases of brain alanine were also observed and, together with previous reports of increased concentrations of alpha-ketoglutarate, are consistent with ammonia-induced inhibition of alpha-ketoglutarate dehydrogenase in the brains of spf/Y mice. Increased brain content of the excitatory amino acid aspartate could be responsible for the seizures frequently encountered in congenital OTC deficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914668     DOI: 10.1007/bf01996073

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  16 in total

1.  Hyperammonaemia causes many of the changes found after portacaval shunting.

Authors:  J Jessy; A M Mans; M R DeJoseph; R A Hawkins
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice.

Authors:  L Ratnakumari; I A Qureshi; R F Butterworth
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

3.  Distribution of glutamine synthetase in the rat central nervous system.

Authors:  M D Norenberg
Journal:  J Histochem Cytochem       Date:  1979-03       Impact factor: 2.479

4.  Abnormal ornithine carbamoyltransferase in mice having the sparse-fur mutation.

Authors:  R DeMars; S L LeVan; B L Trend; L B Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

5.  Accumulation of large neutral amino acids in the brain of sparse-fur mice at hyperammonemic state.

Authors:  I Inoue; T Gushiken; K Kobayashi; T Saheki
Journal:  Biochem Med Metab Biol       Date:  1987-12

6.  Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease.

Authors:  I A Qureshi; J Letarte; R Ouellet
Journal:  Pediatr Res       Date:  1979-07       Impact factor: 3.756

7.  Study of enzyme defect in a case of ornithine transcarbamylase deficiency.

Authors:  I A Qureshi; J Letarte; R Quellet
Journal:  Diabete Metab       Date:  1978-12

8.  Severe cerebral damage in ornithine transcarbamylase deficiency.

Authors:  C L Dolman; R A Clasen; K Dorovini-Zis
Journal:  Clin Neuropathol       Date:  1988 Jan-Feb       Impact factor: 1.368

Review 9.  Ammonia: key factor in the pathogenesis of hepatic encephalopathy.

Authors:  R F Butterworth; J F Giguère; J Michaud; J Lavoie; G P Layrargues
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

10.  Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy.

Authors:  J F Giguère; R F Butterworth
Journal:  Neurochem Res       Date:  1984-09       Impact factor: 3.996

View more
  10 in total

1.  Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy.

Authors:  V Rangroo Thrane; A S Thrane; J Chang; J Chanag; V Alleluia; E A Nagelhus; M Nedergaard
Journal:  Neuroscience       Date:  2012-06-21       Impact factor: 3.590

Review 2.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

3.  Urea cycle defects and hyperammonemia: effects on functional imaging.

Authors:  Andrea L Gropman; Morgan Prust; Andrew Breeden; Stanley Fricke; John VanMeter
Journal:  Metab Brain Dis       Date:  2012-11-13       Impact factor: 3.584

Review 4.  Effects of hyperammonaemia on brain function.

Authors:  R F Butterworth
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

5.  Loss of [3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency.

Authors:  L Ratnakumari; I A Qureshi; R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

Review 6.  Profiling of astrocyte properties in the hyperammonaemic brain: shedding new light on the pathophysiology of the brain damage in hyperammonaemia.

Authors:  U Lichter-Konecki
Journal:  J Inherit Metab Dis       Date:  2008-08-09       Impact factor: 4.982

Review 7.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

Review 8.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

9.  Region-specific causal mechanism in the effects of ammonia on cerebral glucose metabolism in the rat brain.

Authors:  Nobuyuki Maruoka; Tetsuhito Murata; Naoto Omata; Hironori Mitsuya; Yasushi Kiyono; Hidehiko Okazawa; Yuji Wada
Journal:  J Neural Transm (Vienna)       Date:  2012-11-04       Impact factor: 3.575

10.  Gene expression profiling of astrocytes from hyperammonemic mice reveals altered pathways for water and potassium homeostasis in vivo.

Authors:  Uta Lichter-Konecki; Jean Marie Mangin; Heather Gordish-Dressman; Eric P Hoffman; Vittorio Gallo
Journal:  Glia       Date:  2008-03       Impact factor: 7.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.